Body impedance studies in end-stage heart failure

Area of Science:

• Biomedical Engineering
• Cardiology
• Physiology

Background:

• Body impedance analysis (BIA) is a non-invasive method to assess body composition.
• Previous BIA applications have not extensively included patients with end-stage heart failure.
• Understanding fluid status is critical in managing heart failure.

Purpose of the Study:

• To investigate the feasibility and findings of BIA in male patients with end-stage heart failure awaiting transplantation.
• To compare BIA-derived parameters between heart failure patients and healthy controls.
• To explore alterations in intracellular water (ICW) and extracellular water (ECW) in this patient group.

Main Methods:

• BIA measurements were performed on 23 male patients with end-stage heart failure.
• Data from heart failure patients were compared to 69 age-, sex-, height-, and weight-matched healthy controls.
• Statistical analysis was used to compare groups.

Main Results:

• BIA measurements were successfully obtained in end-stage heart failure patients.
• Patients with end-stage heart failure exhibited significantly increased reactance (p<0.01) compared to controls.
• An altered intracellular water/extracellular water ratio (p<0.03) was observed, driven by increased ICW (p<0.01) and decreased ECW (p<0.01).

Conclusions:

• Body impedance analysis is a viable method for assessing body composition in end-stage heart failure patients.
• End-stage heart failure is associated with distinct changes in body water composition, including increased reactance and a shift towards higher intracellular water.
• These findings suggest BIA can provide valuable insights into fluid status and body composition in heart failure management.